|
KIAA0922 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.203200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.182760E-01 |
| Normal-vs-Stage2 |
5.918200E-01 |
| Normal-vs-Stage3 |
6.401400E-01 |
| Normal-vs-Stage4 |
6.792600E-01 |
| Stage1-vs-Stage2 |
4.756000E-01 |
| Stage1-vs-Stage3 |
1.920420E-01 |
| Stage1-vs-Stage4 |
6.133000E-01 |
| Stage2-vs-Stage3 |
4.479800E-01 |
| Stage2-vs-Stage4 |
9.905800E-01 |
| Stage3-vs-Stage4 |
6.095400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.038000E-01 |
| Normal-vs-AfricanAmerican |
3.821000E-01 |
| Normal-vs-Asian |
5.208000E-01 |
| Caucasian-vs-AfricanAmerican |
8.974400E-01 |
| Caucasian-vs-Asian |
2.019800E-01 |
| AfricanAmerican-vs-Asian |
1.997040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.102000E-02 |
| Normal-vs-Female |
7.378200E-01 |
| Male-vs-Female |
1.998480E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.794100E-02 |
| Normal-vs-Extreme_Weight |
9.550500E-02 |
| Normal-vs-Obese |
9.052400E-01 |
| Normal-vs-Extreme_Obese |
1.922380E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.501200E-01 |
| Normal_Weight-vs-Obese |
4.884300E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.585200E-01 |
| Extreme_Weight-vs-Obese |
1.536650E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.948800E-01 |
| Obese-vs-Extreme_Obese |
1.703950E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.569960E-01 |
| Normal-vs-Age(41-60Yrs) |
9.810800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.672100E-02 |
| Normal-vs-Age(81-100Yrs) |
9.896400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.283800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.398900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.321300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.021600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.435200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.551000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.644000E-02 |
| Normal-VS-Type2 PRCC |
2.411800E-01 |
| Normal-VS-KIRP CIMP |
5.037400E-04 |
| Normal-VS-Unclassified PRCC |
8.658000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.082000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.15850000004247E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
3.935800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.368400E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.593800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.018120E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.884400E-01 |
| Normal-vs-N1 |
3.223400E-01 |
| Normal-vs-N2 |
7.226400E-01 |
| N0-vs-N1 |
1.040250E-01 |
| N0-vs-N2 |
5.433200E-01 |
| N1-vs-N2 |
8.646200E-01 |
|
|
